Monday, December 16, 2019

Antitrust in Life Science conference - March 23, 2020

23 March 2020

Antitrust in Life Sciences


Date & place

Monday 23 March 2020 13:30-18:30

Add to calendar
Fordham Law School

150 West 62nd Street

10023 New York United States of America
Show map




Welcome Remarks


James Keyte | Director, Fordham Competition Law Institute

Opening Keynote Discussion: US/EU, A Transatlantic Gap?


Noah Joshua Phillips | Commissioner, US Federal Trade Commission, Washington DC
Paul Csiszár | Director, Antitrust Unit Pharma and Health services, European Commission - DG COMP, Brussels
Discussant: Dr. Lisa Cameron | Principal, The Brattle Group, Boston

Panel 1: Generics Exclusion: What Conduct Crosses the Lines? - Product Hoping, Patent Settlement, Class Certification...


Elinor Hoffmann | Deputy Chief, Antitrust Bureau, Office of the NY State Attorney General, New York
Eric Stock | Partner, Gibson Dunn, New York
Jeffrey Bank | Partner, Wilson Sonsini Goodrich & Rosati, Washington, DC*
Mark Gidley | Partner, White & Case, Washington, DC*
George Gordon | Partner, Dechert, Philadelphia*
Christine Siegwarth Meyer | Managing Director, NERA Economic Consulting, White Plains
Moderator: Martin Gaynor | Professor of Economics & Health Policy, Carnegie Mellon University, Pittsburgh



Panel 2: Do Pharmaceutical Mergers Harm Consumers?


Max Miller | Assistant Attorney General, Antitrust, Office of the Iowa State Attorney General, Des Moines*
Marc Brotman | VP & Assistant General Counsel, Chief Antitrust Counsel, Pfizer, New York
Patricia Danzon | Professor of Healthcare Management, The Wharton School, University of Pennsylvania, Philadelphia
George Rozanski | Partner, Bates White, Washington, DC
Moderator: Robert Willig | Professor of Economics and Public Affairs, Princeton University



Panel 3: The Counsel’s Perspective: How to ensure Antitrust Compliance?


Ryan Foley | Sr. Corporate Counsel, Antitrust Americas, Novartis, New York
Brian Savage | General Counsel, US Generics, Teva Pharmaceuticals, Parsippany
Erin Darling | Associate Vice President & Counsel, Federal Policy, Merck, Washington, DC*
F. Ty Edmondson | Chief Corporation Counsel, Biogen, Boston*
Agnieszka Gallagher | General Counsel and Chief Compliance Officer, ViiV Healthcare, Chapel Hill*
Lara Levitan | Vice President, Legal, AbbVie, Chicago*
Jill Ondos | Global Deputy General Counsel, Mylan, Pittsburgh*
Boris Bershteyn | Partner, Skadden, New York*
Paul Greenberg | Managing Principal, Analysis Group, Boston*

Closing Keynote Discussion


Gail Levine | Deputy Director, Bureau of Competition, US Federal Trade Commission, Washington, DC
Scott Hemphill | Professor of Law, New York University School of Law, New York



* To Be Confirmed

All conference attendees will be eligible for complimentary 48-hour Concurrences+ subscription.


This is the inaugural edition of this joint conference co-organized by Concurrences and Fordham Competition Law Institute, in partnership with the sponsors. Attendance is by registration only. No on-site registration. Seats are limited.

Upon request, Fordham Law School will submit applications to state bar associations in New York, or New Jersey for up to 3 continuing legal education (CLE) credits. Please note that CLE credit approval is ultimately at the discretion of individual states and no advance assurance can be given that credit will be granted in all cases.

The conference and its speakers will be filmed by Concurrences to be posted online. Photos of the speakers and of the attendees will also be taken. By entering the conference premises, you understand that you may be photographed and you hereby give Concurrences the unqualified right to take pictures and/or recordings of you.

In case of over registration, attendance will be limited to one representative per institution, at the discretion of the organizer.

| Permalink


Post a comment